Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2012; 18(20): 2545-2553
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2545
Table 1 Study characteristics
AuthorsYrDesignRegionPopulation sizeCase populationReference populationConfounders adjusted for
Ha et al[43]2010Case-controlSouth Korean = 292 (EE), n = 500 (NERD)Single hospitalHospital controlsG, E, T, J, OD, WHR, TG
Nam et al[44]2010CohortSouth Korean = 495 (EE), n = 3779 (normal)General populationGeneral populationWC , WHR , VAT , SAT
Wang et al[46]2010Case-controlChinan = 70 (EE), n = 502 (non-EE)General populationGeneral populationA, G, S, B, T, E, C, tea drinking, spicy food consumption, betel nut use
Koo et al[45]2009Case-controlSouth Korean = 42 (EE), n = 987 (control)General populationGeneral populationG, T, E, TG ,
Koo et al[45]2009Case-controlSouth Korean = 42 (EE), n = 1007 (control)General populationGeneral populationG, T, E, TG ,
Chua et al[47]2009Case-controlTaiwan, Chinan = 427 (EE), n = 427 (control)Single hospitalHospital controlsTG, Glucose intolerance, HDL-C, SBP
Song et al[48]2009Case-controlSouth Korean = 639 (EE), n = 5443 (non-EE)Single hospitalHospital controlsA, G, T, E, H, TC, HDL-C, LDL-C, TG, BP, fasting glucose
Lien et al[49]2009Case-controlTaiwan, Chinan = 102 (EE), n = 1942 (non-EE)Single hospitalHospital controlsA, G, J
Lien et al[49]2009Case-controlTaiwan, Chinan = 240 (EE), n = 1662 (non-EE)Single hospitalHospital controlsA, G, J
Nam et al[50]2009CohortSouth Korean = 552 (EE), n = 8019 (non-EE)General populationGeneral populationA, WC, E, T
Lee et al[51]2009Case-controlSouth Korean = 100 (EE), n = 100 (control)Single hospitalHospital controlsWHR, T, J, VAT, SAT, VAT/SAT
Chung et al[52]2008Case-controlSouth Korean = 3539 (EE), n = 3539 (control )Single hospitalHospital controlsE, T, metabolic syndrome
Zagari et al[53]2008Cross-sectionalItalyn = 122 (EE), n = 911 (non-EE)General populationGeneral populationA, G, E, T, H, J, C, medication use, peptic ulcer
Lee et al[54]2008Case-controlSouth Korean = 292 (EE), n = 2896 (control)Medical centerMedical centerG, TC, TG, WHR, J, T, OD, PBF
Kim et al[42]2008Case-controlSouth Korean = 1810 (EE), n = 20154 (normal)Multiple hospitalMultiple hospitalG, E, J, H, TC, TG, T, medications for liver/heart disease
Moki et al[56]2007Case-controlJapann = 191 (EE), n = 4968 (non-EE)General populationGeneral populationA, G, BP, TG, FBG
Kim et al[58]2007Case-controlSouth Korean = 1090 (EE), n = 26229 (non-EE)Single hospitalHospital controlsA, G, E, T
Nocon et al[55]2007CohortGermanyn = 5289 (EE), n = 926 (non-EE)General populationGeneral populationA, T, E,
Kang et al[57]2007Cross-sectionalSouth Korean = 161 (EE), n = 2281 (non-EE)Single hospitalHospital controlsA, G, J, T, B, hypertensive drugs, lifestyle choices, abdominal obesity
Labenz et al[8]2004Cross-sectionalGermanyn = 2455 (EE), n = 2834 (control)Medical centerMedical centerA, G, R, S, T, E, B, H, concomitant disease, concomitant medicatons
Nilsson et al[12]2002Case-controlSwedenn = 179 (EE), n = 179 (control)Multiple hospitalMultiple hospitalT, cholecystectomy, I, drugs use
Wilson et al[59]1999Case-controlUnited Statesn = 189 (EE), n = 1024 (control)Single hospitalSingle hospitalA, G, J, R
Stene-Larsen et al[4]1988Cross-sectionalSwedenn = 195 (EE), n = 1029 (control)Single hospitalSingle hospitalNone